Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5220375
Max Phase: Preclinical
Molecular Formula: C27H32N2O5
Molecular Weight: 464.56
Associated Items:
ID: ALA5220375
Max Phase: Preclinical
Molecular Formula: C27H32N2O5
Molecular Weight: 464.56
Associated Items:
Canonical SMILES: CN(CCCOc1ccc2ccc(=O)oc2c1)Cc1cccc(OC(=O)NC2CCCCC2)c1
Standard InChI: InChI=1S/C27H32N2O5/c1-29(15-6-16-32-23-13-11-21-12-14-26(30)34-25(21)18-23)19-20-7-5-10-24(17-20)33-27(31)28-22-8-3-2-4-9-22/h5,7,10-14,17-18,22H,2-4,6,8-9,15-16,19H2,1H3,(H,28,31)
Standard InChI Key: RIBSWIDLITYLHS-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 464.56 | Molecular Weight (Monoisotopic): 464.2311 | AlogP: 5.12 | #Rotatable Bonds: 9 |
Polar Surface Area: 81.01 | Molecular Species: BASE | HBA: 6 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: 8.60 | CX LogP: 4.73 | CX LogD: 3.50 |
Aromatic Rings: 3 | Heavy Atoms: 34 | QED Weighted: 0.35 | Np Likeness Score: -0.80 |
1. Zhang H, Wang Y, Wang Y, Li X, Wang S, Wang Z.. (2022) Recent advance on carbamate-based cholinesterase inhibitors as potential multifunctional agents against Alzheimer's disease., 240 [PMID:35858523] [10.1016/j.ejmech.2022.114606] |
Source(1):